Tumor Necrosis Factor and Splenectomy

Kaynakça (7)

1. Tanyong D, Panichob P, Kheansaard W, Fucharoen S. Effect of tumor necrosis factor-alpha on erythropoietin- and erythropoietin receptor-induced erythroid progenitor cell proliferation in β-thalassemia/hemoglobin E patients. Turk J Hematol 2015;32:304-310
2. Hiroyoshi T, Tsuchida M, Uchiyama K, Fujikawa K, Komatsu T, Kanaoka Y, Matsuyama H. Splenectomy protects the kidneys against ischemic reperfusion injury in the rat. Transpl Immunol 2012;27:8-11
3. Chuncharunee S, Archararit N, Hathirat P, Udomsubpayakul U, Atichartakarn V. Levels of serum interleukin-6 and tumor necrosis factor-a in postsplenectomized thalassemic patients. J Med Assoc Thai 1997;80(Suppl 1):S86-S91
4. Wanachiwanawin W, Wiener E, Siripanyaphinyo U, Chinprasertsuk S, Mawas F, Fucharoen S, Wickramasinghe S, Pootrakul P, Visudhiphan S. Serum levels of tumor necrosis factor-α, interleukin-1, and interferon-γ in β0- thalassemia/HbE and their clinical significance. J Interferon Cytokine Res 1999;19:105-111
5. Belcher JD, Marker PH, Weber JP, Hebbel RP. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000;96:2451-2459
6. Banyatsuppasin W, Butthep P, Atichartakarn V, Thakkinstian A, Archararit N, Pattanapanyasat K, Chuncharunee S. Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients. Am J Hematol 2011;86:89-92
7. Del Vecchio GC, Schettini F, Piacente L, De Santis A, Giordano P, De Mattia D. Effects of deferiprone on immune status and cytokine pattern in thalassaemia major. Acta Haematol 2002;108:144-149.